SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:144476996"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:144476996" > Impact of deviation...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Ho, PJ (author)

Impact of deviation from guideline recommended treatment on breast cancer survival in Asia

  • Article/chapterEnglish2020

Publisher, publication year, extent ...

  • 2020-01-28
  • Springer Science and Business Media LLC,2020

Numbers

  • LIBRIS-ID:oai:prod.swepub.kib.ki.se:144476996
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:144476996URI
  • https://doi.org/10.1038/s41598-020-58007-5DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Breast cancer survival has improved with significant progress in treatment and disease management. However, compliance with treatment varies. Treatment guidelines for older patients are unclear. We aim to identify predictors of noncompliance with recommended therapy in a large breast cancer population and assess the impact of noncompliance on survival. Our study included 19,241 non-metastatic female breast cancer patients, of whom 3,158 (16%) died within 10 years post-diagnosis (median survival = 5.8 years). We studied the association between treatment noncompliance and factors with logistic regression, and the impact of treatment noncompliance on survival with a flexible parametric survival model framework. The highest proportion of noncompliance was observed for chemotherapy (18%). Predictors of noncompliance with chemotherapy, radiotherapy and endocrine therapy included age, tumor size, nodal involvement and subtype (except radiotherapy). Factors associated with not receiving surgery included age and subtype. Treatment noncompliance was associated with worse overall survival for surgery (HR: 2.26 [1.80–2.83]), chemotherapy (1.25 [1.11–1.41]), radiotherapy (2.28 [1.94–2.69]) and endocrine therapy (1.70 [1.41–2.04]). Worse survival was similarly observed in older patients for whom guidelines generally do not apply. Our results highlight the importance of following appropriate treatment as recommended by current guidelines. Older patients may benefit from similar recommendations.

Added entries (persons, corporate bodies, meetings, titles ...)

  • Ow, SGW (author)
  • Sim, YR (author)
  • Liu, J (author)
  • Lim, SH (author)
  • Tan, EY (author)
  • Tan, SM (author)
  • Lee, SC (author)
  • Tan, VKM (author)
  • Yap, YS (author)
  • Chay, WY (author)
  • Tan, BKT (author)
  • Wong, FY (author)
  • Li, JM (author)
  • Hartman, M (author)

Related titles

  • In:Scientific reports: Springer Science and Business Media LLC10:1, s. 1330-2045-2322

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view